Browsing by Author Oza, Amit

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)Citation
2014Development of the Measure of Ovarian Symptoms and Treatment Concerns: Aiming for Optimal Measurement of Patient-Reported Symptom Benefit with Chemotherapy for Symptomatic Ovarian CancerButow, Phyllis; Friedlander, Michael; Gillies, Kim Michelle; King, Madeleine; Martyn, Julie; Mercieca-Bebber, Rebecca; O'Connell, Rachel; Sjoquist, Katrin; Stockler, Martin; Voysey, Merryn; Donovan, Heidi; Oza, Amit; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreDevelopment of the Measure of Ovarian Symptoms and Treatment Concerns: Aiming for Optimal Measurement of Patient-Reported Symptom Benefit with Chemotherapy for Symptomatic Ovarian Cancer, International Journal of Gynecological Cancer, vol.24, 5, 2014,pp 865-873
2013Hope, Quality of Life, and Benefit From Treatment in Women Having Chemotherapy for Platinum-Resistant/Refractory Recurrent Ovarian Cancer: The Gynecological Cancer Intergroup Symptom Benefit StudyButow, Phyllis; Friedlander, Michael; Gillies, Kim Michelle; King, Madeleine; Martyn, Julie; O'Connell, Rachel; Sjoquist, Katrin; Stockler, Martin; Voysey, Merryn; Oza, Amit; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreHope, Quality of Life, and Benefit From Treatment in Women Having Chemotherapy for Platinum-Resistant/Refractory Recurrent Ovarian Cancer: The Gynecological Cancer Intergroup Symptom Benefit Study, The Oncologist, vol.18, 11, 2013,pp 1221-1228
2011A phase 3 trial of bevacizumab in ovarian cancerBeale, Philip; Carey, Mark; Cervantes, Andres; Collinson, Fiona; du Bois, Andreas; Essapen, Sharadah; Gourley, Charlie; Kimmig, R; Kristensen, Gunnar; Kurzeder, Christian; Ledermann, Jonathan; Lemenin, Arto; Lortholary, Alain; Mirza, Mansoor Raza; Oza, Amit; Parmar, M. K. B.; Perren, Timothy; Pfisterer, J.; Plante, Marie; Pujade-Lauraine, Eric; Qian, Wendi; Sehouli, Jalid; Selle, Frederic; Stahle, Anne; Stark, Dan; Swart, Ann Marie; Central Clinical School: MedicineA phase 3 trial of bevacizumab in ovarian cancer, New England Journal of Medicine, vol.365, 26, 2011,pp 2484-2496
2017Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit StudyBuizen, L; King, Madeleine; O'Connell, Rachel; Roncolato, Felicia; Stockler, Martin; Aotani, Enriko; Avall-Lundqvist, Elisabeth; Berek, Jonathan; Berton-Rigaud, Dominique; Donnellan, Paul; Feeney, Amanda; Friedlander, M; Heitz, Florian; Hilpert, Felix; Joly, F; Lanceley, Anne; Okamoto, Aikou; Oza, Amit; Pignata, Sandro; NH&MRC Clinical Trials Centre; Psychology; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreReducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study, The Oncologist, vol.22, 9, 2017,pp 1117-1124
2011Supporting Treatment Decision Making in Advanced Cancer: A Randomized Trial of a Decision Aid for Patients With Advanced Colorectal Cancer Considering ChemotherapyBeale, Philip; Butow, Phyllis; Clarke, Stephen; Goldstein, David; Horvath, Lisa; Shepherd, Heather; Tattersall, Martin; Wilcken, Nicholas; Chen, Eric; Feld, R; Hedley, David; Knox, Jennifer; Krzyzanowska, Monika; Leighl, Natasha B; McJannett, Margaret; Moore, Malcolm; Oza, Amit; Xu, Wei; Central Clinical School: Medicine; Psychology; Concord Clinical School: ANZAC Research Institute; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; School of Public Health: Public Health; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead)Supporting Treatment Decision Making in Advanced Cancer: A Randomized Trial of a Decision Aid for Patients With Advanced Colorectal Cancer Considering Chemotherapy, Journal of Clinical Oncology, vol.29, 15, 2011,pp 2077-2084
2014Symptom burden and outcomes of patients with platinum resistant/refractory recurrent ovarian cancer: a reality check: results of stage 1 of the gynecologic cancer intergroup symptom benefit studyButow, Phyllis; Friedlander, Michael; Gillies, Kim Michelle; King, Madeleine; Martyn, Julie; O'Connell, Rachel; Sjoquist, Katrin; Stockler, Martin; Voysey, Merryn; Donovan, Heidi; Oza, Amit; Symptom Benefit Study Group, .; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreSymptom burden and outcomes of patients with platinum resistant/refractory recurrent ovarian cancer: a reality check: results of stage 1 of the gynecologic cancer intergroup symptom benefit study, International Journal of Gynecological Cancer, vol.24, 5, 2014,pp 857-864
2009Symptom control in patients with recurrent ovarian cancer: measuring the benefit of palliative chemotherapy in women with platinum refractory/resistant ovarian cancer.Butow, Phyllis; Gainford, Corona; King, Madeleine; Martyn, Julie; Stockler, Martin; Donovan, Heidi; Friedlander, Michael; Miller, Brigitte; Oza, Amit; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreSymptom control in patients with recurrent ovarian cancer: measuring the benefit of palliative chemotherapy in women with platinum refractory/resistant ovarian cancer., International Journal Of Gynecological Cancer, vol.19, Suppl 2,pp S44-S48